These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 39226680)
1. Tanomastat exerts multi-targeted inhibitory effects on viral capsid dissociation and RNA replication in human enteroviruses. Lim TYM; Jaladanki CK; Wong YH; Yogarajah T; Fan H; Chu JJH EBioMedicine; 2024 Sep; 107():105277. PubMed ID: 39226680 [TBL] [Abstract][Full Text] [Related]
2. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C. Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X J Virol; 2021 May; 95(12):. PubMed ID: 33789997 [TBL] [Abstract][Full Text] [Related]
3. Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications. Sun J; Yogarajah T; Lee RCH; Kaur P; Inoue M; Tan YW; Chu JJH Sci Rep; 2020 May; 10(1):8159. PubMed ID: 32424333 [TBL] [Abstract][Full Text] [Related]
4. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors. Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909 [TBL] [Abstract][Full Text] [Related]
5. Effects and mechanism of Aβ Zhong M; Wang H; Yan H; Wu S; Wang K; Yang L; Cui B; Wu M; Li Y Virol J; 2022 Sep; 19(1):151. PubMed ID: 36127711 [TBL] [Abstract][Full Text] [Related]
6. Identification of fangchinoline as a broad-spectrum enterovirus inhibitor through reporter virus based high-content screening. Zhang QY; Li JQ; Li Q; Zhang Y; Zhang ZR; Li XD; Zhang HQ; Deng CL; Yang FX; Xu Y; Zhang B Virol Sin; 2024 Apr; 39(2):301-308. PubMed ID: 38452856 [TBL] [Abstract][Full Text] [Related]
7. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid. Sun L; Lee H; Thibaut HJ; Lanko K; Rivero-Buceta E; Bator C; Martinez-Gualda B; Dallmeier K; Delang L; Leyssen P; Gago F; San-Félix A; Hafenstein S; Mirabelli C; Neyts J PLoS Pathog; 2019 May; 15(5):e1007760. PubMed ID: 31071193 [TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of Mulberroside C against enterovirus A71 in vitro and in vivo. Cao Y; Lei E; Li L; Ren J; He X; Yang J; Wang S Eur J Pharmacol; 2021 Sep; 906():174204. PubMed ID: 34051220 [TBL] [Abstract][Full Text] [Related]
9. Doxycycline inhibits neurotropic enterovirus proliferation in vitro. Chi F; Liu X; Li J; Guo M; Zhang Z; Zhou H; Carr MJ; Li Y; Shi W Virus Res; 2024 Jul; 345():199388. PubMed ID: 38714218 [TBL] [Abstract][Full Text] [Related]
10. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate. Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71. Ho JY; Chern JH; Hsieh CF; Liu ST; Liu CJ; Wang YS; Kuo TW; Hsu SJ; Yeh TK; Shih SR; Hsieh PW; Chiu CH; Horng JT J Antimicrob Chemother; 2016 Jul; 71(7):1922-32. PubMed ID: 27098012 [TBL] [Abstract][Full Text] [Related]
12. Discovery of 14S-(2'-chloro-4'-nitrophenoxy)-8R/S,17-epoxy andrographolide as EV-A71 infection inhibitor. Dai K; Tan JK; Qian W; Lee RCH; Hann Chu JJ; Zhou GC Biochem Pharmacol; 2021 Dec; 194():114820. PubMed ID: 34748818 [TBL] [Abstract][Full Text] [Related]
13. New potent EV-A71 antivirals targeting capsid. Roux H; Touret F; Coluccia A; Khoumeri O; Di Giorgio C; Majdi C; Sciò P; Silvestri R; Vanelle P; Roche M Eur J Med Chem; 2024 Oct; 276():116658. PubMed ID: 39088999 [TBL] [Abstract][Full Text] [Related]
14. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products. Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182 [TBL] [Abstract][Full Text] [Related]
15. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo. Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X Viruses; 2019 May; 11(5):. PubMed ID: 31121933 [TBL] [Abstract][Full Text] [Related]
16. dsRNA Binding Domain of PKR Is Proteolytically Released by Enterovirus A71 to Facilitate Viral Replication. Chang YH; Lau KS; Kuo RL; Horng JT Front Cell Infect Microbiol; 2017; 7():284. PubMed ID: 28702377 [TBL] [Abstract][Full Text] [Related]
17. Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71). Lalani S; Masomian M; Poh CL Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445463 [TBL] [Abstract][Full Text] [Related]
18. Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo. Cao Y; Lei E; Wang X; Qi X; Li L; Ren J; Yang J; Wang S Antiviral Res; 2021 Nov; 195():105091. PubMed ID: 34044060 [TBL] [Abstract][Full Text] [Related]
19. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71. Hsieh W-S; Chao C-H; Shen C-Y; Cheng D; Huang S-W; Wang Y-F; Chen C-C; Chen S-H; Hsu L-J; Wang J-R J Virol; 2024 Jan; 98(1):e0155823. PubMed ID: 38174926 [TBL] [Abstract][Full Text] [Related]
20. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans. Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]